Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer (Q44644561)
Jump to navigation
Jump to search
scientific article published on December 20, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer |
scientific article published on December 20, 2003 |
Statements
1 reference
Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer (English)
1 reference
1 reference
Koh-ichi Nakashiro
Satoru Shintani
1 reference
Chunnan Li
1 reference
Mariko Mihara
1 reference
Nagaaki Terakado
1 reference
Junya Yano
1 reference
Hiroyuki Hamakawa
1 reference
1 December 2003
1 reference
1 reference
1 reference
107
1 reference
6
1 reference
1030-1037
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference